Teniposide in refractory ovarian cancer: a phase II study

American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics·2026

Expanding the scope of platinum-NHC complexes: trans-Pt(II) and Pt(0) architectures for ovarian cancer treatment.

Dalton transactions (Cambridge, England : 2003)·2026

Oral Anticoagulation Monotherapy vs Dual-Pathway Antithrombotic Therapy in Chronic Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

East meets west: resectable gastric cancer treatment in the era of immune checkpoint inhibitors.

Expert opinion on pharmacotherapy·2026

Perspectives on the use of coercion in highly specialised rehabilitation: a focus group study.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026

Related Experiment Videos

Teniposide in refractory ovarian cancer: a phase II study

Related Concept Videos

A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK).

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey.

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.

The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective.

Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies.

Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.

IV melphalan in children.

Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.

Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.

Doxorubicin distribution in human breast cancer.

Phase I study of echinomycin.

Locoregional recurrence after transaxillary robotic thyroidectomy for differentiated thyroid cancer: long-term outcomes in 10,504 patients.

A multivariable model for treatment duration in nonextraction clear aligner therapy.

Expanding the scope of platinum-NHC complexes: trans-Pt(II) and Pt(0) architectures for ovarian cancer treatment.

Oral Anticoagulation Monotherapy vs Dual-Pathway Antithrombotic Therapy in Chronic Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

East meets west: resectable gastric cancer treatment in the era of immune checkpoint inhibitors.

Perspectives on the use of coercion in highly specialised rehabilitation: a focus group study.

Related Experiment Videos

Teniposide in refractory ovarian cancer: a phase II study

Related Concept Videos

Related Articles